Literature DB >> 20053447

Aberrant Ca2+ handling in lysosomal storage disorders.

Kirill Kiselyov1, Soichiro Yamaguchi, Christopher W Lyons, Shmuel Muallem.   

Abstract

Lysosomal storage diseases (LSDs) are caused by inability of cells to process the material captured during endocytosis. While they are essentially diseases of cellular "indigestion", LSDs affect large number of cellular activities and, as such, they teach us about the integrative function of the cell, as well as about the gaps in our knowledge of the endocytic pathway and membrane transport. The present review summarizes recent findings on Ca2+ handling in LSDs and attempts to identify the key questions on alterations in Ca2+ signaling and membrane transport in this group of diseases, answers to which may lie in delineating the cellular pathogeneses of LSDs. 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20053447      PMCID: PMC2838446          DOI: 10.1016/j.ceca.2009.12.007

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  83 in total

1.  Inhibition of the SERCA Ca2+ pumps by curcumin. Curcumin putatively stabilizes the interaction between the nucleotide-binding and phosphorylation domains in the absence of ATP.

Authors:  J G Bilmen; S Z Khan; M H Javed; F Michelangeli
Journal:  Eur J Biochem       Date:  2001-12

2.  Gain-of-function mutation in TRPML3 causes the mouse Varitint-Waddler phenotype.

Authors:  Hyun Jin Kim; Qin Li; Sandra Tjon-Kon-Sang; Insuk So; Kirill Kiselyov; Shmuel Muallem
Journal:  J Biol Chem       Date:  2007-10-25       Impact factor: 5.157

Review 3.  TRPpathies.

Authors:  Kirill Kiselyov; Abigail Soyombo; Shmuel Muallem
Journal:  J Physiol       Date:  2006-11-30       Impact factor: 5.182

4.  Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects.

Authors:  Marie E Egan; Marilyn Pearson; Scott A Weiner; Vanathy Rajendran; Daniel Rubin; Judith Glöckner-Pagel; Susan Canny; Kai Du; Gergely L Lukacs; Michael J Caplan
Journal:  Science       Date:  2004-04-23       Impact factor: 47.728

5.  A novel mode of TRPML3 regulation by extracytosolic pH absent in the varitint-waddler phenotype.

Authors:  Hyun Jin Kim; Qin Li; Sandra Tjon-Kon-Sang; Insuk So; Kirill Kiselyov; Abigail A Soyombo; Shmuel Muallem
Journal:  EMBO J       Date:  2008-03-27       Impact factor: 11.598

Review 6.  Lysosomal disorders: from storage to cellular damage.

Authors:  Andrea Ballabio; Volkmar Gieselmann
Journal:  Biochim Biophys Acta       Date:  2008-12-08

Review 7.  The neuronal ceroid lipofuscinoses: mutations in different proteins result in similar disease.

Authors:  Jill M Weimer; Elizabeth Kriscenski-Perry; Yasser Elshatory; David A Pearce
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 4.103

8.  STIM1, an essential and conserved component of store-operated Ca2+ channel function.

Authors:  Jack Roos; Paul J DiGregorio; Andriy V Yeromin; Kari Ohlsen; Maria Lioudyno; Shenyuan Zhang; Olga Safrina; J Ashot Kozak; Steven L Wagner; Michael D Cahalan; Gönül Veliçelebi; Kenneth A Stauderman
Journal:  J Cell Biol       Date:  2005-05-02       Impact factor: 10.539

9.  Lysosomal trafficking functions of mucolipin-1 in murine macrophages.

Authors:  Eric G Thompson; Lara Schaheen; Hope Dang; Hanna Fares
Journal:  BMC Cell Biol       Date:  2007-12-21       Impact factor: 4.241

10.  Partial restoration of mutant enzyme homeostasis in three distinct lysosomal storage disease cell lines by altering calcium homeostasis.

Authors:  Ting-Wei Mu; Douglas M Fowler; Jeffery W Kelly
Journal:  PLoS Biol       Date:  2008-02       Impact factor: 8.029

View more
  26 in total

Review 1.  Lysosomal physiology.

Authors:  Haoxing Xu; Dejian Ren
Journal:  Annu Rev Physiol       Date:  2015       Impact factor: 19.318

Review 2.  Fig4 deficiency: a newly emerged lysosomal storage disorder?

Authors:  Colin Martyn; Jun Li
Journal:  Prog Neurobiol       Date:  2012-11-16       Impact factor: 11.685

3.  Cigarette smoke-induced Ca2+ release leads to cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction.

Authors:  Julia E Rasmussen; John T Sheridan; William Polk; Catrin M Davies; Robert Tarran
Journal:  J Biol Chem       Date:  2014-01-21       Impact factor: 5.157

4.  The Resurrection of Phenotypic Drug Discovery.

Authors:  Wayne E Childers; Khaled M Elokely; Magid Abou-Gharbia
Journal:  ACS Med Chem Lett       Date:  2020-03-06       Impact factor: 4.345

5.  Membrane potential regulates nicotinic acid adenine dinucleotide phosphate (NAADP) dependence of the pH- and Ca2+-sensitive organellar two-pore channel TPC1.

Authors:  Volodymyr Rybalchenko; Malini Ahuja; Jessica Coblentz; Dev Churamani; Sandip Patel; Krill Kiselyov; Shmuel Muallem
Journal:  J Biol Chem       Date:  2012-04-12       Impact factor: 5.157

6.  Lipid storage disorders block lysosomal trafficking by inhibiting a TRP channel and lysosomal calcium release.

Authors:  Dongbiao Shen; Xiang Wang; Xinran Li; Xiaoli Zhang; Zepeng Yao; Shannon Dibble; Xian-ping Dong; Ting Yu; Andrew P Lieberman; Hollis D Showalter; Haoxing Xu
Journal:  Nat Commun       Date:  2012-03-13       Impact factor: 14.919

7.  Altered Cellular Homeostasis in Murine MPS I Fibroblasts: Evidence of Cell-Specific Physiopathology.

Authors:  Gustavo Monteiro Viana; Cinthia Castro do Nascimento; Edgar Julian Paredes-Gamero; Vânia D'Almeida
Journal:  JIMD Rep       Date:  2017-02-21

8.  Transient receptor potential mucolipin 1 (TRPML1) and two-pore channels are functionally independent organellar ion channels.

Authors:  Soichiro Yamaguchi; Archana Jha; Qin Li; Abigail A Soyombo; George D Dickinson; Dev Churamani; Eugen Brailoiu; Sandip Patel; Shmuel Muallem
Journal:  J Biol Chem       Date:  2011-05-03       Impact factor: 5.157

9.  Modulating ryanodine receptors with dantrolene attenuates neuronopathic phenotype in Gaucher disease mice.

Authors:  Benjamin Liou; Yanyan Peng; Ronghua Li; Venette Inskeep; Wujuan Zhang; Brian Quinn; Nupur Dasgupta; Rachel Blackwood; Kenneth D R Setchell; Sheila Fleming; Gregory A Grabowski; John Marshall; Ying Sun
Journal:  Hum Mol Genet       Date:  2016-12-01       Impact factor: 6.150

10.  Novel compounds that reverse the disease phenotype in Type 2 Gaucher disease patient-derived cells.

Authors:  Wayne Childers; Rong Fan; Rogelio Martinez; Dennis J Colussi; Edward Melenski; Yuxiao Liu; John Gordon; Magid Abou-Gharbia; Marlene A Jacobson
Journal:  Bioorg Med Chem Lett       Date:  2019-11-11       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.